Company Information

Company Profile

Telomir Pharmaceuticals, Inc. is a clinical-stage oncology company developing Telomir-Zn, an investigational oral small molecule targeting iron-dependent epigenetic mechanisms in cancer. The lead program is focused on triple-negative breast cancer (TNBC), with FDA IND clearance for a Phase 1/2 clinical trial.